Pressemitteilungen

BIOTRONIK Announces Completion of Enrollment in SFA Arm of the BIOFLEX-I Study

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, today announced the completion of patient enrollment in the superficial...

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, today announced that the first patient has been enrolled in the investigator-initiated...

El simposio Cardiostim demuestra las ventajas del BIOTRONIK Home Monitoring® para el tratamiento eficaz de pacientes con insuficiencia cardíaca

, Medical Technology

Durante un simposio científico en el Congreso Cardiostim de este año, el Dr. Gerhard Hindricks, del Centro Cardíaco de la Universidad de Leipzig,...

Physicians Implant World's First ProMRI® Quadripolar CRT-D System to Treat Heart Failure

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the first implantations worldwide of its new ICD and CRT-D...

Ärzte implantieren erstes MRT-fähiges quadripolares CRT-D-System zur Therapie der Herzinsuffizienz

, Medical Technology

BIOTRONIK, ein führender Hersteller kardiovaskulärer Medizintechnik, gab heute die Durchführung der weltweit ersten Implantationen seiner neuen...

Vascular Intervention: BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, has announced the start of enrollment and first Pulsar-18 self-expanding...

BIOTRONIK presenta el nuevo estimulador cardíaco en la conferencia Cardiostim

, Medical Technology

BIOTRONIK, uno de los fabricantes líderes de tecnología médica cardiovascular, está presentando su nuevo estimulador cardíaco en el congreso...

BIOTRONIK presenta il nuovo stimolatore cardiaco al Congresso Cardiostim

, Medical Technology

BIOTRONIK, un produttore leader nel settore della tecnologia medica cardiovascolare, presenta il suo nuovo stimolatore cardiaco al congresso...

BIOTRONIK présente son nouveau stimulateur cardiaque au congrès Cardiostim

, Medical Technology

BIOTRONIK, fabricant leader de technologies médicales cardiovasculaires, a présenté son nouveau stimulateur cardiaque au Cardiostim 2014, le...

Dal congresso Cardiostim: BIOTRONIK Home Monitoring® garantisce una gestione più efficace dei pazienti affetti da insufficienza cardiaca

, Medical Technology

Durante il congresso scientifico Cardiostim di quest'anno, il Dr. Gerhard Hindricks del Centro Cardiologico, Università di Lipsia, Germania,...

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

, Medical Technology

During a scientific symposium at this year's Cardiostim Congress, Dr. Gerhard Hindricks of the Heart Center, University of Leipzig, Germany,...

Cardiostim-Symposium: Verbesserte Herzinsuffizienztherapie durch BIOTRONIK Home Monitoring®

, Medical Technology

Auf einem wissenschaftlichen Symposium im Rahmen des diesjährigen Cardiostim-Kongresses unterstrich Professor Gerhard Hindricks vom Herzzentrum...

BIOTRONIK präsentiert neuen Herzstimulator auf der Cardiostim-Konferenz

, Medical Technology

BIOTRONIK, ein führender Hersteller kardiovaskulärer Medizintechnik, stellt auf der diesjährigen Cardiostim-Konferenz in Nizza seinen neuen Herzstimulator...

BIOTRONIK Presents New Heart Stimulator at Cardiostim Conference

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, is presenting its new heart stimulator at the Cardiostim 2014 electrophysiology...

Media

Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
BIOTRONIK
Woermannkehre 1
D - 12359 Berlin



Ansprechpartner

Frau Manuela Schildwächter


Communications & PR Manager
BIOTRONIK SE & Co. KG

Telefon +49 (30) 689051414


Frau Katharina Sackersdorff


Global Communications
Communications & PR

Telefon +49 (30) 68905-1423
Fax +49 (30) 6890596-1423


alle Ansprechpartner
Disclaimer